Unicycive Therapeutics Inc (NASDAQ: UNCY) is -13.59% lower on its value in year-to-date trading and has touched a low of $0.20 and a high of $1.82 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The UNCY stock was last observed hovering at around $0.66 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $0.69, the stock is -6.23% and 6.77% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.95 million and changing 3.30% at the moment leaves the stock 4.71% off its SMA200. UNCY registered -29.97% loss for a year compared to 6-month gain of 38.67%. The firm has a 50-day simple moving average (SMA 50) of $0.63874 and a 200-day simple moving average (SMA200) of $0.659255.
The stock witnessed a -14.00% loss in the last 1 month and extending the period to 3 months gives it a 91.28%, and is -11.91% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.69% over the week and 11.20% over the month.
Unicycive Therapeutics Inc (UNCY) has around 14 employees, a market worth around $71.24M and $0.00M in sales. Distance from 52-week low is 239.75% and -62.25% from its 52-week high. The company has generated returns on investments over the last 12 months (-106.78%).
The EPS is expected to grow by 59.82% this year, but quarterly earnings will post -100.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Unicycive Therapeutics Inc (UNCY) Top Institutional Holders
25.0 institutions hold shares in Unicycive Therapeutics Inc (UNCY), with institutional investors hold 41.00% of the company’s shares. The shares outstanding are 97.86M, and float is at 87.47M with Short Float at 1.41%. Institutions hold 38.24% of the Float.
The top institutional shareholder in the company is VIVO CAPITAL, LLC with over 3.47 million shares valued at $1.74 million. The investor’s holdings represent 9.9395% of the UNCY Shares outstanding. As of 2024-06-30, the second largest holder is LOGOS GLOBAL MANAGEMENT LP with 3.47 million shares valued at $1.74 million to account for 9.9389 of the shares outstanding. The other top investors are NANTAHALA CAPITAL MANAGEMENT, LLC which holds 2.82 million shares representing 8.0783% and valued at over $1.41 million, while RA CAPITAL MANAGEMENT, L.P. holds 7.5394 of the shares totaling 2.63 million with a market value of $1.32 million.
Unicycive Therapeutics Inc (UNCY) Insider Activity
#####
